Versant Capital Management, Inc - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2023$599
-4.5%
70.0%0.00%
Q3 2023$627
-38.6%
7
-41.7%
0.00%
Q2 2023$1,022
+37.2%
12
+33.3%
0.00%
Q1 2023$745
+5.2%
90.0%0.00%
Q4 2022$708
-29.2%
90.0%0.00%
Q3 2022$1,0000.0%90.0%0.00%
Q2 2022$1,0000.0%90.0%0.00%
Q1 2022$1,00090.0%0.00%
Q4 2021$0
-100.0%
90.0%0.00%
Q3 2021$1,0000.0%90.0%0.00%
Q2 2021$1,0000.0%90.0%0.00%
Q1 2021$1,0000.0%90.0%0.00%
Q4 2020$1,00090.0%0.00%
Q3 2020$090.0%0.00%
Q2 2020$0
-100.0%
9
-55.0%
0.00%
-100.0%
Q1 2020$1,000
-50.0%
200.0%0.00%0.0%
Q4 2019$2,0000.0%200.0%0.00%0.0%
Q3 2019$2,000
-33.3%
20
-31.0%
0.00%0.0%
Q2 2019$3,000
-88.5%
29
-82.1%
0.00%
-83.3%
Q1 2019$26,000
-31.6%
162
-57.5%
0.01%
-66.7%
Q4 2018$38,000
-13.6%
381
-2.6%
0.02%0.0%
Q3 2018$44,000
+15.8%
391
-9.7%
0.02%
+12.5%
Q2 2018$38,000
+15.2%
433
-4.8%
0.02%
+14.3%
Q1 2018$33,000
+26.9%
455
-1.3%
0.01%
+27.3%
Q4 2017$26,000
+85.7%
461
+43.2%
0.01%
+37.5%
Q3 2017$14,000
+16.7%
322
+3.5%
0.01%
+14.3%
Q2 2017$12,000
+33.3%
311
+36.4%
0.01%
+40.0%
Q1 2017$9,0000.0%228
-3.0%
0.01%0.0%
Q4 2016$9,000
-18.2%
235
-25.9%
0.01%
-16.7%
Q3 2016$11,000
+175.0%
317
+91.0%
0.01%
+200.0%
Q2 2016$4,000
-55.6%
166
-37.8%
0.00%
-60.0%
Q1 2016$9,000
+12.5%
267
-4.0%
0.01%0.0%
Q4 2015$8,0002780.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders